Medi Caps
MEDICAPQ NSE
Medi Caps
HealthcareNSE: MEDICAPQ BSE: 523144 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹41.15 Cr
Volatility
Low Risk
P/E Ratio
-24.5
EBITDA
₹-1.20 Cr
Return on Equity
-2.72%
Debt to Equity
0
Book Value
₹89.5
52W High
₹36.8
52W Low
₹20.33
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.59 times its book value
Weaknesses
3- Company has low interest coverage ratio.
- Company has a low return on equity of 1.68% over last 3 years.
- Company has high debtors of 466 days.
Growth Rate
Revenue Growth
-26.6% lower than
3Y
Net Income Growth
400% higher than
3Y
Cash Flow Change
-238% lower than
3Y
ROE
479% higher than
3Y
ROCE
299% higher than
3Y
EBITDA Margin (Avg.)
-282% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 2.13 | 3.05 | 1.97 | 0.29 | 0.98 | 0.26 | 0.89 | 0 | 1 | 0.77 | 0.53 | 0.1 |
| Expenses | 0.37 | 0.16 | 0.87 | 0.93 | 0.69 | 0.59 | 0.57 | 0.68 | 0.67 | 0.68 | 0.59 | 0.87 | 0.64 |
| Operating Profit | -0.35 | 1.97 | 2.18 | 1.04 | -0.4 | 0.39 | -0.31 | 0.21 | -0.67 | 0.32 | 0.18 | -0.34 | -0.54 |
| OPM % | -1750% | 92.49% | 71.48% | 52.79% | -137.93% | 39.8% | -119.23% | 23.6% | — | 32% | 23.38% | -64.15% | -540% |
| Other Income | 0.01 | 0 | 0 | 0.14 | 0.11 | 0.1 | 0.09 | 0.27 | 0.31 | 0.01 | 0.17 | 0.08 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.05 |
| PBT | -0.38 | 1.93 | 2.14 | 1.14 | -0.33 | 0.45 | -0.26 | 0.44 | -0.4 | 0.29 | 0.31 | -0.33 | -0.59 |
| Tax % | 0% | 0% | 21.03% | 42.98% | 0% | 0% | 0% | -61.36% | 0% | 0% | 9.68% | -3.03% | 0% |
| Net Profit | -0.38 | 1.93 | 1.69 | 0.65 | -0.33 | 0.45 | -0.26 | 0.71 | -0.4 | 0.29 | 0.29 | -0.31 | -0.59 |
| EPS in Rs | -0.3 | 1.55 | 1.36 | 0.52 | -0.26 | 0.36 | -0.21 | 0.57 | -0.32 | 0.23 | 0.23 | -0.25 | -0.47 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.37 | 25.04 | 22.76 | 26.38 | 25.28 | 10.91 | 0 | 0 | 0.1 | 7.17 | 2.42 | 2.31 | 2.4 |
| Expenses | 25.52 | 23.42 | 21.99 | 25.93 | 25.32 | 19.97 | 0 | 0.56 | 0.39 | 2.33 | 2.53 | 2.83 | 2.78 |
| Operating Profit | 1.85 | 1.62 | 0.77 | 0.45 | -0.04 | -9.06 | 0 | -0.56 | -0.29 | 4.84 | -0.11 | -0.52 | -0.38 |
| OPM % | 6.76% | 6.47% | 3.38% | 1.71% | -0.16% | -83.04% | — | — | -290% | 67.5% | -4.55% | -22.51% | -15.83% |
| Other Income | 1.21 | 0.46 | 1.13 | 0.67 | 1.14 | 1.11 | -0.12 | 0.64 | 0.53 | 0.15 | 0.56 | 0.58 | 0.26 |
| Interest | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.32 | 0.33 | 0.37 | 0.34 | 0.35 | 0.36 | 0 | 0.09 | 0.09 | 0.16 | 0.16 | 0.19 | 0.2 |
| PBT | 2.73 | 1.74 | 1.51 | 0.76 | 0.71 | -8.32 | -0.12 | -0.02 | 0.15 | 4.83 | 0.29 | -0.13 | -0.32 |
| Tax % | 29.3% | 32.18% | 23.18% | 26.32% | 16.9% | 0.12% | -8.33% | 50% | 0% | 19.46% | -93.1% | 15.38% | — |
| Net Profit | 1.94 | 1.18 | 1.16 | 0.56 | 0.59 | -8.33 | -0.11 | -0.04 | 0.15 | 3.89 | 0.56 | -0.14 | -0.32 |
| EPS in Rs | 1.56 | 0.95 | 0.93 | 0.45 | 0.47 | -6.68 | -0.09 | -0.03 | 0.12 | 3.12 | 0.45 | -0.11 | -0.26 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Reserves | 51.89 | 53.07 | 53.9 | 54.45 | 55.04 | 47.38 | 48.5 | 48.82 | 48.64 | 54.02 | 54.87 | 54.24 |
| Borrowings | 0 | 0 | 0 | 0.17 | 0.12 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 4.58 | 5.47 | 5.64 | 4.73 | 6.16 | 1.65 | 1.66 | 0.52 | 0.52 | 1.6 | 0.68 | 0.63 |
| Total Liabilities | 68.94 | 71.01 | 72.01 | 71.82 | 73.79 | 61.56 | 62.63 | 61.81 | 61.63 | 68.09 | 68.02 | 67.34 |
| Fixed Assets | 3.96 | 3.64 | 4.96 | 5.01 | 4.99 | 3.63 | 3.26 | 2.78 | 2.46 | 3.34 | 3.18 | 3.31 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 |
| Investments | 48.25 | 49.56 | 49.29 | 49.81 | 50.67 | 52.15 | 54.39 | 53.68 | 51.98 | 54.03 | 55.81 | 55.13 |
| Other Assets | 16.73 | 17.81 | 17.76 | 17 | 18.13 | 5.78 | 4.98 | 5.35 | 7.19 | 10.72 | 8.95 | 8.9 |
| Total Assets | 68.94 | 71.01 | 72.01 | 71.82 | 73.79 | 61.56 | 62.63 | 61.81 | 61.63 | 68.09 | 68.02 | 67.34 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 6.88 | 1.44 | 2.7 | 0.86 | 1.33 | -0.92 | 2.24 | -0.95 | -2.6 | 3.09 | 1.85 | -0.47 |
| Investing | -6.78 | -1.31 | -1.76 | -0.96 | -1.19 | -0.4 | -2.19 | 1.01 | 1.85 | -3.09 | -1.85 | 0.42 |
| Financing | 0 | 0 | 0 | 0.17 | -0.05 | -0.06 | -0.06 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.1 | 0.13 | 0.94 | 0.07 | 0.09 | -1.38 | -0.02 | 0.06 | -0.75 | 0 | 0.01 | -0.05 |
| Free Cash Flow | 6.59 | 1.44 | 2.09 | 0.46 | 1 | -0.92 | 2.28 | -0.65 | -2.45 | 3.13 | 1.78 | -0.72 |
| CFO/OP | 412 | 122 | 394 | 231 | -3,575 | 10 | — | 170 | 897 | 83 | -1,445 | 85 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88.55 | 96.35 | 97.18 | 96.02 | 90.24 | 88.99 | — | — | 8,176 | 237 | 552 | 466 |
| Inventory Days | 194 | 248 | 282 | 219 | 266 | 20.89 | 1,825 | — | — | — | — | — |
| Days Payable | 33.53 | 60.03 | 83.09 | 55.89 | 118 | 16.56 | 1,095 | — | — | — | — | — |
| Cash Conversion Cycle | 249 | 285 | 296 | 259 | 239 | 93.33 | — | — | 8,176 | 237 | 552 | 466 |
| Working Capital Days | 159 | 176 | 179 | 157 | 159 | 132 | — | — | 25,623 | 481 | 1,297 | 1,357 |
| ROCE % | 4.29% | 2.69% | 1.52% | 1.14% | 0.77% | -13.56% | 0% | -0.85% | -0.62% | 7.34% | -0.13% | -0.91% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Medi Caps insights
38 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN, KYC Details, Bank Account Details, Nomination And Other Details.
5 May - Physical shareholders asked to furnish PAN, KYC, bank details and nomination to RTA. 5 May - Physical shareholders asked to furnish PAN, KYC, bank details and nomination to RTA.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
8 Apr - Medi-Caps says it is not a Large Corporate; outstanding borrowing was nil as of 31 March 2026. 8 Apr - Medi-Caps says it is not a Large Corporate; outstanding borrowing was nil as of 31 March 2026.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026. 4 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026.
4
Information For Shareholders Regarding Opening Of Special Window For Transfer And Dematerialization Of Physical Securities.
4 Apr - SEBI special window for physical securities transfer/demat opens February 5, 2026 to February 4, 2027. 4 Apr - SEBI special window for physical securities transfer/demat opens February 5, 2026 to February 4, 2027.
Frequently Asked Questions about Medi Caps
What does Medi Caps Ltd do?
Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals[1]
Where is Medi Caps Ltd (523144) listed?
Medi Caps Ltd trades as MEDICAPQ on the NSE and under code 523144 on the BSE.
Which sector does Medi Caps Ltd belong to?
Medi Caps Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Medi Caps Ltd?
Medi Caps Ltd has a market capitalisation of ₹41.15 Cr, which places it in the Small Cap band.
What is the PE ratio of Medi Caps Ltd?
Medi Caps Ltd trades at a PE ratio of -24.50, against a book value of ₹89.5 per share.
What is the 52-week high and low of Medi Caps Ltd?
Over the last 52 weeks Medi Caps Ltd has traded between ₹20.33 and ₹36.8.
What is the Return on Equity (ROE) of Medi Caps Ltd?
Medi Caps Ltd reported a return on equity of -2.72%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523144.md for Medi Caps Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.